Clinical Trial Update: The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update investigating folinic acid rescue after methotrexate-based GVHD prophylaxis to reduce regimen-related toxicity and influence tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Mucositis

Drugs mentioned

• Leucovorin (folinic acid)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Rabin Medical Center | Conditions: Graft vs Host Disease, Allogeneic Hematopoietic Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN